ராபர்ட் கர்ன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ராபர்ட் கர்ன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ராபர்ட் கர்ன் Today - Breaking & Trending Today

Lyra Therapeutics : Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual


New data presented includes:
- First product candidate found to be effective in non-polyp patients in addition to polyp patients in a clinical trial, based on 100% of patients in both groups achieving SNOT-22 MCID at week 24 with LYR-210 (7500µg group) -
- LYR-210 (7500µg) decreased ethmoid opacification at week 24, a measure of disease modification -
- LYR-210 (7500µg) reduced the need for rescue medication -
- Separately, Lyra also reported an analysis showing that LYR-210 (7500µg) achieved statistically significant improvement across 3 cardinal symptoms at week 24 in the LANTERN study -
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today presented data from its Phase 2 LANTERN study of LYR-210, the company’s lead long-acting product candidate fo ....

Robert Kern , Anders Cervin , Maria Palasis , Rodney Williams Memorial Foundation , University Of Queensland , Lyra Therapeutics Inc , Lyra Therapeutics , Combined Otolaryngology Spring Meetings , Professor Anders Cervin , Garnett Passe , Rodney Williams Memorial Foundation Chair , Principal Investigator , Oral Presentation , Non Polyp Patients , Cardinal Symptoms , Chief Medical Officer , Chief Executive Officer , Inc Stock Exchange , Press Release , Both Lyra , ராபர்ட் கர்ன் , ரோட்னி வில்லியம்ஸ் நினைவகம் அடித்தளம் , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து , லைரா சிகிச்சை இன்க் , லைரா சிகிச்சை , கார்னெட் கடந்த காலம் ,

Chutes & Ladders—Zimmer Biomet calls on Medtronic vet Jamali to lead spinout


Samir Mody as chief commercial officer, while 
Friedrich Asmus signs on as SVP, clinical development and medical affairs. Meanwhile, the company has also tapped 
Joel Centeno as SVP, manufacturing, quality and supply chain. Mody comes over from Medtronic, where he was vice president, CRHF strategy, health economics and reimbursement. Asmus previously served as VP of clinical development at ophthalmology biotech ProQR Therapeutics, while Centeno comes over after stints at Boston Scientific, Hologic and AltheaDx.
Tamra Adams as chief financial officer, a newly created executive position at the company. Before joining Antios, Adams founded Accounting Concepts, which provided CFO, accounting, and financial services to emerging growth companies in the biopharmaceutical and information technology industries, including Engage Therapeutics. ....

United States , United Kingdom , Matteo Levisetti , Aeglea Biotherapeutics , Fraiser Kansteiner , Friedrich Asmus , Tamra Adams , Mcdavid Stilwell , Zimmer Biomet , Pharmas Roche , Rockley Photonics , Bridget Okeeffe , Robert Kern , Peter Calveley , Natalie Holles , Saurabh Saha , Georgea Sisson , Charles Albright , Moncef Slaoui , Richard Kim , Petra Kaufmann , Joel Centeno , Francesco De Rubertis , Coherus Biosciences , Samir Mody , Vafa Jamali ,